-- Almost half of the world’s population has no or limited access to diagnostics

-- This situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIV

-- New partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treated

-- Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals
-- Improving access to reliable diagnostics for disease management in countries with the highest burden
-- Early detection of infectious diseases with diagnostics helps clinicians save lives

-- New tests on cobas 6800/8800 systems provide clinicians information to help speed treatment and reduce the spread of infection
-- Rising challenge of drug resistance compounds the tuberculosis global health crisis
-- Mycobacteria test menu allows detection of tuberculosis, drug resistant tuberculosis and nontuberculous mycobacteria infections from single patient sample